New‐onset inflammatory bowel disease in adults with atopic dermatitis
New‐onset inflammatory bowel disease in adults with atopic dermatitis
复制标题
DOI：
10.1111/jdv.14157
复制
发表时间：
2017-08
影响因子：
9.2
通讯作者：
A. Egeberg;N. Wienholtz;G. Gislason;L. Skov;J. Thyssen
中科院分区：
文献类型：
--
作者：
A. Egeberg;N. Wienholtz;G. Gislason;L. Skov;J. Thyssen
在丹麦和丹麦皮肤科医生和全科医生的一项调查（LEO Pharma）中，维生素D类似物是新诊断患者和接受长期局部治疗的患者最常用的治疗方法。总之，我们报告了丹麦银屑病患者在开始生物治疗前使用的局部和全身非生物治疗的详细列表。在这些患者中，强效皮质类固醇和维生素D类似物是最广泛使用的局部药物，甲氨蝶呤是最广泛使用的全身性非生物制剂。这项工作由Robert Wehnerts og Kirsten Wehnerts Fonden和诺和诺德基金会（NNF 15 OC 0017622）资助。Skov博士曾获得AbbVie、Pfizer、Janssen-Cilag、Merck Sharp & Dohme和Leo Pharma的顾问和/或演讲者酬金，并且是AbbVie、Pfizer、Leo Pharma、Janssen-Cilag、Merck Sharp & Dohme、Eli Lilly、Celgene和Novartis的顾问委员会成员。
favoured treatments for psoriasis in Denmark and in a survey among Danish dermatologists and general practitioners (by LEO Pharma), it was indicated that vitamin D analogues were the most frequently used treatment for newly diagnosed patients and for patients receiving prolonged topical treatment. In summary, we report a detailed list of topical and systemic non-biologic treatments used by Danish patients with psoriasis prior to initiating biologic treatment. In these patients, potent corticosteroids and vitamin D analogues are the most widely used topical agents and methotrexate the most widely used systemic non-biologic agent. The work was funded by Robert Wehnerts og Kirsten Wehnerts Fonden and the Novo Nordisk Foundation (NNF15OC0017622). Dr. Skov has received consultancy and/or speaker honoraria from AbbVie, Pfizer, Janssen-Cilag, Merck Sharp & Dohme, and Leo Pharma and is a member of the advisory boards of AbbVie, Pfizer, Leo Pharma, Janssen-Cilag, Merck Sharp & Dohme, Eli Lilly, Celgene and Novartis.